BLOG

Monday, June 22, 2020

Gilead aims remdesivir supply for 2 million Covid-19 patients by year-end

The company also said it hoped to start trials in August of an easier-to-use inhaled version of the medicine, currently administered only intravenously

from Companies https://ift.tt/2Z3xmm4
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...